76
Views
23
CrossRef citations to date
0
Altmetric
Original Research

The prognostic and predictive value of the combination of the neutrophil-to-lymphocyte ratio and the platelet-to-lymphocyte ratio in patients with hepatocellular carcinoma who receive transarterial chemoembolization therapy

, , &
Pages 1391-1400 | Published online: 12 Feb 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Leijuan Gan, Shaohua Ren, Mengran Lang, Guangtao Li, Feng Fang, Lu Chen, Yayue Liu, Ruyu Han, Kangwei Zhu & Tianqiang Song. (2022) Predictive Value of Preoperative Serum AFP, CEA, and CA19-9 Levels in Patients with Single Small Hepatocellular Carcinoma: Retrospective Study. Journal of Hepatocellular Carcinoma 9, pages 799-810.
Read now
Shamar Young, Isa Cam, Mehmet Gencturk, Nathan Rubin, Donna D’souza, Siobhan Flanagan, Jafar Golzarian & Tina Sanghvi. (2021) Inflammatory Scores: Comparison and Utility in HCC Patients Undergoing Transarterial Chemoembolization in a North American Cohort. Journal of Hepatocellular Carcinoma 8, pages 1513-1524.
Read now
Hongyu Wang, Chuyang Lin, Wenzhe Fan, Jiang Zhang, Yingqiang Zhang, Wang Yao & Jiaping Li. (2020) Dynamic Changes in the Neutrophil-to-Lymphocyte Ratio Predict the Prognosis of Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization. Cancer Management and Research 12, pages 3433-3444.
Read now

Articles from other publishers (19)

Mitsuru Yanagaki, Shinji Onda, Takeshi Gocho, Yosuke Igarashi, Yoshihiro Shirai, Norimitsu Okui, Michinori Matsumoto, Taro Sakamoto, Koichiro Haruki & Toru Ikegami. (2024) Prognostic impact of osteosarcopenia in patients undergoing pancreatic resection for pancreatic ductal adenocarcinoma. Langenbeck's Archives of Surgery 409:1.
Crossref
Anita Karimi, Hooman Yarmohammadi & Joseph P. Erinjeri. (2024) Immune Effects of Intra-Arterial Liver-Directed Therapies. Journal of Vascular and Interventional Radiology 35:2, pages 178-184.
Crossref
Xu Chen, Abdul Fatawu Mohammed & Chengbin Li. (2024) Assessment of the Clinical Value of Platelet-to-Lymphocyte Ratio in Patients with Hepatocellular Carcinoma. Clinical and Applied Thrombosis/Hemostasis 30.
Crossref
Mitsuru Yanagaki, Koichiro Haruki, Tomohiko Taniai, Yosuke Igarashi, Jungo Yasuda, Kenei Furukawa, Shinji Onda, Yoshihiro Shirai, Masashi Tsunematsu & Toru Ikegami. (2022) The significance of osteosarcopenia as a predictor of the long‐term outcomes in hepatocellular carcinoma after hepatic resection. Journal of Hepato-Biliary-Pancreatic Sciences 30:4, pages 453-461.
Crossref
Yan‐Xin Chen, Lin Du, Li‐Nan Wang, Yong‐Yong Shi, Min Liao, Min Zhong & Gao‐Feng Zhao. (2022) Effects of Dexmedetomidine on Systemic Inflammation and Postoperative Complications in Laparoscopic Pancreaticoduodenectomy: A Double‐blind Randomized Controlled Trial. World Journal of Surgery 47:2, pages 500-509.
Crossref
Roberto Minici, Maria Anna Siciliano, Michele Ammendola, Rita Carlotta Santoro, Vito Barbieri, Girolamo Ranieri & Domenico Laganà. (2022) Prognostic Role of Neutrophil-to-Lymphocyte Ratio (NLR), Lymphocyte-to-Monocyte Ratio (LMR), Platelet-to-Lymphocyte Ratio (PLR) and Lymphocyte-to-C Reactive Protein Ratio (LCR) in Patients with Hepatocellular Carcinoma (HCC) undergoing Chemoembolizations (TACE) of the Liver: The Unexplored Corner Linking Tumor Microenvironment, Biomarkers and Interventional Radiology. Cancers 15:1, pages 257.
Crossref
Meng-Ying Peng, Zhi-Gang Zuo, Feng-Jun Cao, Yuan-Dong Yu, Xiao-Jun Cai & Guo-Xing Wan. (2022) Elevated Preoperative NMPR Predicts an Unfavorable Chance of Survival in Resectable Esophageal Squamous Cell Carcinoma. Medicina 58:12, pages 1808.
Crossref
Xiaohan Shi, ·Huayu Li, ·Yongxiang Xu, ·Alphonce M. K. Nyalali & ·Feng Li. (2022) The prognostic value of the preoperative inflammatory index on the survival of glioblastoma patients. Neurological Sciences 43:9, pages 5523-5531.
Crossref
Jing-Houng Wang, Yen-Yang Chen, Kwong-Ming Kee, Chih-Chi Wang, Ming-Chao Tsai, Yuan-Hung Kuo, Chao-Hung Hung, Wei-Feng Li, Hsiang-Lan Lai & Yen-Hao Chen. (2022) The Prognostic Value of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Patients with Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab. Cancers 14:2, pages 343.
Crossref
Mitsuru Yanagaki, Koichiro Haruki, Jungo Yasuda, Kenei Furukawa, Shinji Onda, Masashi Tsunematsu, Yoshihiro Shirai, Takeshi Gocho, Tomohiko Taniai, Ryoga Hamura & Toru Ikegami. (2021) The Significance of the Rapid Turnover Protein Score as a Predictor of the Long-Term Outcomes in Hepatocellular Carcinoma After Hepatic Resection. Annals of Surgical Oncology 28:13, pages 8130-8139.
Crossref
Wenlong Wu, Quancheng Wang, Dandan Han, Jianhui Li, Ye Nie, Dongnan Guo, Long Yang, Kaishan Tao, Xuan Zhang & Kefeng Dou. (2021) Prognostic value of preoperative inflammatory markers in patients with hepatocellular carcinoma who underwent curative resection. Cancer Cell International 21:1.
Crossref
Bo Li, Aixia Liu, Yi Wen, Guang Yang, Jing Zhao, Xiaohan Li, Yuanli Mao & Boan Li. (2021) The prognostic values of serum markers in hepatocellular carcinoma after invasive therapies based on real‐world data. Journal of Clinical Laboratory Analysis 35:9.
Crossref
Lei Zhang, Zhi-Ping Yan, Zhong-Heng Hou, Peng Huang, Min-Jie Yang, Shuai Zhang, Shen Zhang, Shao-Hua Zhang, Xiao-Li Zhu, Cai-Fang Ni & Qiang Li. (2021) Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Predictors of Outcomes in Patients With Unresectable Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization Plus Sorafenib. Frontiers in Molecular Biosciences 8.
Crossref
Mohamad Mouchli, Shravani Reddy, Miranda Gerrard, Lisa Boardman & Marrieth Rubio. (2021) Usefulness of neutrophil-to-lymphocyte ratio (NLR) as a prognostic predictor after treatment of hepatocellular carcinoma." Review article. Annals of Hepatology 22, pages 100249.
Crossref
Shuxin Sun, Chaobin He, Jun Wang, Xin Huang, Jiali Wu & Shengping Li. (2020) The prognostic significance of inflammation-based scores in patients with ampullary carcinoma after pancreaticoduodenectomy. BMC Cancer 20:1.
Crossref
Young Chang, Soung Won Jeong, Jae Young Jang & Yong Jae Kim. (2020) Recent Updates of Transarterial Chemoembolilzation in Hepatocellular Carcinoma. International Journal of Molecular Sciences 21:21, pages 8165.
Crossref
Shuangshuang Li, Xudong Feng, Guodong Cao, Qianhui Wang & Ling Wang. (2020) Prognostic significance of inflammatory indices in hepatocellular carcinoma treated with transarterial chemoembolization: A systematic review and meta-analysis. PLOS ONE 15:3, pages e0230879.
Crossref
Mengque Xu, Mengsha Cen, Xiaoli Chen, Haotian Chen, Xing Liu & Qian Cao. (2019) Correlation between Serological Biomarkers and Disease Activity in Patients with Inflammatory Bowel Disease. BioMed Research International 2019, pages 1-7.
Crossref
Q. Wang, P. Zhao, N. He, J. P. Sun, K. Li, C. R. Zang, Y. N. Zhao, Y. Zhao & Y. H. Zhang. (2019) Combination of the gamma-glutamyltransferase-to-prealbumin ratio and other indicators may be a novel marker for predicting the prognosis of patients with hepatocellular carcinoma undergoing locoregional ablative therapies. Infectious Agents and Cancer 14:1.
Crossref